cll14: feasibility of fixed-duration frontline therapy in cll
Published 1 year ago • 154 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:56
the future of fixed-duration therapy in cll
-
2:41
fixed-duration vs continuous therapy in cll
-
0:56
fixed-duration treatment strategies for frontline and relapsed cll
-
4:05
comparing continuous and fixed duration therapy in cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:36:57
mapping the new era in cll management with precision medicine
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
17:13
chronic lymphocytic leukemia treatment & side effects (venetoclax & obinutuzumab) | tamsin (3 of 3)
-
2:51
the optimum approach to frontline treatment of cll in 2021
-
12:46
fixed duration treatment strategies in cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
0:57
unanswered questions in frontline cll treatment
-
2:27
update on fixed-duration cohort of captivate trial for cll/sll
-
5:03
understanding patient perspectives in cll treatment
-
1:28
the future of cll treatment
-
1:15
optimizing initial therapy of cll
-
0:53
the future of cll treatment
-
1:33
future advancements in the treatment of cll
-
1:25
the management of cll in italy
-
3:28
the importance of the life cycle of cll cells and how it can inform treatment
-
1:39
the importance of diagnostic testing in cll
-
1:19
cll treatment: a look into the future